EU Outsources Key Tobacco Control Responsibilities to Third Parties

Feb.27.2023
EU Outsources Key Tobacco Control Responsibilities to Third Parties
The EU outsources tobacco control responsibilities to non-elected bodies, causing concerns over accountability and potential conflicts of interest.

The European Tobacco Harm Reduction Advocates (ETHRA) has stated that the EU has outsourced key responsibilities for tobacco control to unelected organizations. ETHRA coordinates the actions of consumer groups and advocacy organizations throughout Europe. The organization warns that this has raised concerns about accountability and potential conflicts of interest.


EU officials had issued a tender notice for the "Support Action for the Tobacco Control Sector Single Framework Contract" earlier. Recently, they announced that the process has been completed and three contractors have been appointed.


The Spanish research and consultancy firm, Open Evidence, ...


The European Network for Smoking Prevention (ENSP)


Crete University


ETHRA has released a publicly available report which states that as part of their contribution, they will lead an "international consortium". This consortium will include the UK's ICF consultancy company, Brussels-based Milieu legal and policy consultancy, and Vital Strategies funded by Michael Bloomberg.


According to the Consumer Association, the contract will last for four years and is worth 3 million euros (approximately 22.03 million yuan).


According to the statement from ETHRA, the contractor's job will include:


Gather scientific literature, research, or clinical evaluations related to one or more tobacco or nicotine themes.


2. Statistical, market, and measurement analyses related to one or more tobacco or nicotine themes.


Tobacco Control Policy Model,


Behavioral research and analysis of specific issues.


Support for comprehensive health warnings,


Support for tobacco and related product labelling and packaging.


7. Restrictions on ingredients and related content/emission standards.


Support technological investment in information system development.


Conduct a legal assessment for the tobacco control measures of the European Union, countries, and international organizations.


The European Tobacco Harm Reduction Advocates (ETHRA) stated that the introductory notes in the tender specifications of the European Health and Digital Executive Agency (HaDEA) provide the legislative background of the EU's tobacco control policies, with the goal of achieving a "smoke-free tobacco generation" by 2040.


To achieve this goal, the plan is to revise the Tobacco Products Directive, which includes measures such as "implementing plain packaging and banning flavors in a completely transparent manner, improving the evaluation of ingredients through existing EU institutions, expanding taxes to new tobacco products, and addressing tobacco advertising, promotion, and sponsorship on the internet and social media.


According to the author of the document, there are concerns about the regulatory framework of the European Union. Currently, there is no systematic approach to dealing with all new tobacco and emerging products, and there is also a lack of flexibility to address rapidly developing products.


Advocates for reducing the harm of tobacco in Europe say, "This appears to be a daunting task for contractors. More importantly, it signifies that the policy-making responsibilities of the European Commission are now being outsourced to third parties. Accountability issues arise as well: when EU member states receive proposals to amend existing legislation, how do they know which proposals come from responsible officials and what role external actors played in shaping EU legislation?


Another issue is the potential conflict of interest with the winning bidder group. Of course, when it comes to the tobacco industry, they have a responsibility to declare that they have no conflict of interest in the tobacco industry. However, their work may have potential conflicts with other industries, such as the pharmaceutical industry that we may not be aware of.


References:


Efforts to Lobby on Behalf of Tobacco Industry The European Union (EU) has been found to be subcontracting its efforts to control tobacco, potentially undermining efforts to combat smoking. Investigations have discovered that the EU is employing companies which have links to the tobacco industry, leading to allegations of lobbying on behalf of the sector. The subcontractors are tasked with implementing tobacco control policies to be carried out across EU member states. Critics have voiced concern that this conflict of interest could threaten progress in reducing rates of smoking across Europe.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Product | JNR Launches Crown Shisha 100K for International Wholesale, Pairing 58ml Capacity With Triple-Mesh DTL Design
Product | JNR Launches Crown Shisha 100K for International Wholesale, Pairing 58ml Capacity With Triple-Mesh DTL Design
JNR released the Crown Shisha 100K on August 14, 2026, positioning the ultra-high-capacity disposable around a direct-to-lung (DTL) e-shisha experience. The device combines a 58ml e-liquid capacity, triple 1.0Ω mesh coils and a 1,300mAh rechargeable battery, with JNR claiming up to 100,000 puffs. Adjustable airflow, battery and e-liquid status displays, a leather-style exterior and a shisha-inspired sound effect further differentiate the product. JNR is currently promoting the device through international wholesale and distribution channels, while a specific first retail market has not been disclosed.
Aug.31
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
2Firsts Exclusive Analysis | RLX Q2 Revenue Rises 14.8%, Company Takes Control of Western European Distributor and Expands Multi-Category Strategy
business accounting for 68.5% of sales. A new controlling investment in a Western European distributor and plans to scale modern oral nicotine pouches point to a broader international strategy spanning channels and multiple product categories.
Special Report
Aug.14